Le Lézard
Classified in: Health, Science and technology, Business
Subjects: LIC, TRI

CompleWare and VIDA Announce Joint Marketing Agreement for Respiratory Trials


IOWA CITY, Iowa, Sept. 26, 2017 /PRNewswire/ -- CompleWare and VIDA announce a joint marketing agreement promoting complementary respiratory services. Their partnership will deploy a best-in-class pulmonary platform and excellence in clinical trial management, with precision, ISO-certified core lab imaging. 

"CompleWare and VIDA provide unique service offerings in the respiratory therapeutic area," said Dr. John M. Weiler, CompleWare's President. "Their synergy will lead to a strong joint value proposition to customers."

CompleWare software and contract research organization (CRO) services will facilitate complete respiratory development programs. This will provide specialized and insightful experts to support global respiratory trials. VIDA and CompleWare will provide precision lung imaging informatics, delivered through core lab imaging services (Precision Services) and interactive software (VIDA|vision®). This solution spans the care cycle, from detection through treatment across a range of pulmonary diseases: COPD (including severe emphysema, chronic bronchitis), lung cancer, and asthma.

CompleWare and VIDA offer unprecedented pulmonary expertise. CompleWare has provided services to the pharmaceutical industry for the collection and management of clinical trial data for >30 years. Drawing on multi-disciplinary expertise in pulmonology, radiology, and electrical and biomedical engineering, VIDA has become an innovator in precision pulmonary imaging.  VIDA has supported numerous academic and industry trials for >10 years, cited in >200 peer-reviewed publications.

The CompleClinical® application is a comprehensive eClinical solution for clinical trial data capture and management. The VIDA|vision pulmonary suite of software and services provides unparalleled breadth and depth of analysis, empowering chest physicians with advanced, quantitative information to help inform care decisions. 

"We are thrilled to be partnering with CompleWare, merging our advanced quantitative lung imaging with expert respiratory trial management to offer a great dynamic to meet the endpoints of tomorrow's pulmonary medicine," said Jered Sieren, Director of Clinical Research & Development at VIDA.

About CompleWare
CompleWare is a full service CRO and software vendor for the clinical trials industry. For more information, visit www.compleware.com.

About VIDA
VIDA focuses on changing the practice of pulmonary care with data-driven, personalized services that aid early detection, evaluation, and treatment planning for lung diseases, including lung cancer, obstructive airway diseases, and asthma.  VIDA's software and services are cleared for clinical use in the United States, Canada, European Union, and Australia.  VIDA is headquartered in Coralville, IA, with an additional office in Minneapolis, MN. More at www.vidadiagnostics.com.

 

SOURCE CompleWare; VIDA


These press releases may also interest you

at 15:05
nVent Electric plc ("nVent"), a global leader in electrical connection and protection solutions, will report first quarter 2024 financial results on Friday, May 3, 2024. The company also will hold a conference call with analysts and investors at...

at 15:00
The Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, will participate in a site visit to highlight the federal budget's investments in support of Canadian small businesses. Media are invited to join the Minister...

at 15:00
The Flowery, the leading name in the Florida medical cannabis industry renowned for its commitment to the highest quality and authentic experiences, proudly announces its unique collaboration with Udonis Haslem, a 3-time NBA Champion and legendary...

at 14:55
PIMCO Canada Corp. ("PIMCO Canada") is pleased to announce today that it has declared monthly distributions on its Class A Units (the "Units") of the PIMCO Canada closed end funds (the "Funds"). The distributions will be paid on May 14, 2024 to the...

at 14:48
Loyal, the San Francisco-based company dedicated to improving the health and longevity of dogs, and Prelude, the leading animal health-focused electronic data capture (EDC) system for clinical research, are proud to announce their strategic...

at 14:45
The federal government recently delivered Budget 2024: Fairness for Every Generation.  It is a plan to build a Canada that works better for everyone, where younger generations can get ahead, where their hard work pays off, and where they can buy a...



News published on and distributed by: